Back to browse

Reversal of ovarian cancer multidrug resistance by a combination of LAH4-L1-siMDR1 nanocomplexes with chemotherapeutics

Paper ID

PAPER000210

Year

2018

DOI

10.1021/acs.molpharmaceut.8b00031

PMID

29621396

Journal

Molecular Pharmaceutics

Source URL

Experiments

• EXP001251 with LAH4-L1 (siRNA)